Abstract:Gestation day 11 (GD11) and 14 (GD14) embryos were cultured for up to 4 hours in the presence of Dofetilide (0.01-0.50 microgram/ml), a potent Class III Antiarrhythmic which selectively inhibits the rapid component of the time dependent outward potassium current (IKr). Significant (P < or = 0.05) reductions in heart rate (HR) as measured over a 4 hour period were dose dependent and reversible. The sensitivity of the GD11 embryos was greater than GD14 embryos (14-64% decrease in HR vs. an 11-43% decrease in HR,… Show more
“…Developmental toxicity occurred at doses causing no adverse effects in the mothers, with the exception of the two deaths that will be discussed later in this section. The observed sotalol-induced embryonic death in this study is in accordance with what has been shown for other Ikr blockers in studies in rats (Ban et al 1994;Spence et al 1994;Marks & Terry 1996;Webster et al 1996) and in mice (Skö ld & Danielsson, 2000). Single-dose administration during Day 9, 10, 11, 12, 13, or 14 of the selective Ikr blockers dofetilide and almokalant in rats (Spence et al 1994;Webster et al 1996) resulted in embryonic death.…”
Section: Discussionsupporting
confidence: 92%
“…These data suggest that Ikr channels are expressed and functional when the embryonic heart starts beating, which occurs on Day 9.6 in the rat (Ban et al 1994). The results also suggest that the rabbit is a sensitive species for induction of developmental toxicity of Ikr blockers in the same way as has previously been shown for the mouse and the rat (see above) (Spence et al 1994;Webster et al 1996). However, in contrast to the rat where the Ikr channel is most likely suppressed in favour of other repolarisation ion channels on Days 14-15, developmental toxicity was also observed on Days 15-16 in the rabbit.…”
Section: Discussionsupporting
confidence: 79%
“…In rodent embryos cultured in vitro during the susceptible period, a dose-dependent occurrence of embryonic bradycardia, arrhythmia and cardiac arrest has been noticed for almokalant and dofetilide (Spence et al 1994;Webster et al 1996) and L-691,121 (Ban et al 1994). The results in these in vivo and in vitro studies show a very good correlation between maternal concentrations, which were related with embryonic death, and concentrations that caused severe dysrhythmia.…”
Section: Discussionmentioning
confidence: 88%
“…In rat embryo, a susceptible period seems to exist between Days 9-14. Embryos cultured in vitro during this period show dose-dependent bradycardia, arrhythmia and cardiac arrest after exposure to almokalant, dofetilide and L-691,121 (Spence et al 1994;Webster et al 1996). Pharmacologically induced embryonic bradycardia and arrhythmia have been proposed to be the underlying mechanism for developmental toxicity observed after administration of these agents in vivo in rodents (Abrahamsson et al 1994;Webster et al 1996;Skö ld & Danielsson 2000).…”
The purpose of this study was to investigate the potential of sotalol to cause developmental toxicity in the pregnant rabbit. Sotalol is a b-adrenoceptor blocking drug which also has class III antiarrhythmic properties via Ikr channel blockade. Experiment 1: Nine pregnant New Zealand White rabbits were given doses of either 300, 225, or 150 mg/kg of sotalol during gestational days, called Days, 13-16 which resulted in total litter loss. Experiment 2: A single dose of sotalol, 100 or 150 mg/kg was administered during Days 8-17 to 15 rabbits. Dosing on Day 8, 9, or 10 resulted in a slightly higher incidence of embryonic death compared to historical controls. There was marked increased embryonic death of 55-90% (four does with total litter loss), decreased number of live foetuses per litter, and elevated mean foetal weight after dosing during Days 12-16. Experiment 3: 16 pregnant rabbits were administered single doses of sotalol of either 100, 85, 75, 60 or 50 mg/kg on Day 14. The main finding was increased embryonic death, which ranged from total litter loss to ∂30% at 50 mg/kg. At 50 mg/kg, the maternal C max , AUC 1-24 hr , and t 1/2 were approximately 45 mM, 340 mmol¿hr/l, and 6 hr, respectively. In conclusion, sotalol treatment resulted in embryonic death in the rabbit in early pregnancy in the same way as has been seen for other drugs with Ikr blocking properties (class III antiarrhythmics) in rodents. The observed developmental toxicity in the rabbit is most likely secondary to embryonic arrhythmia as has been shown in rodent studies. The results may indicate that Ikr blocking agents are developmental toxicants across species including man.
“…Developmental toxicity occurred at doses causing no adverse effects in the mothers, with the exception of the two deaths that will be discussed later in this section. The observed sotalol-induced embryonic death in this study is in accordance with what has been shown for other Ikr blockers in studies in rats (Ban et al 1994;Spence et al 1994;Marks & Terry 1996;Webster et al 1996) and in mice (Skö ld & Danielsson, 2000). Single-dose administration during Day 9, 10, 11, 12, 13, or 14 of the selective Ikr blockers dofetilide and almokalant in rats (Spence et al 1994;Webster et al 1996) resulted in embryonic death.…”
Section: Discussionsupporting
confidence: 92%
“…These data suggest that Ikr channels are expressed and functional when the embryonic heart starts beating, which occurs on Day 9.6 in the rat (Ban et al 1994). The results also suggest that the rabbit is a sensitive species for induction of developmental toxicity of Ikr blockers in the same way as has previously been shown for the mouse and the rat (see above) (Spence et al 1994;Webster et al 1996). However, in contrast to the rat where the Ikr channel is most likely suppressed in favour of other repolarisation ion channels on Days 14-15, developmental toxicity was also observed on Days 15-16 in the rabbit.…”
Section: Discussionsupporting
confidence: 79%
“…In rodent embryos cultured in vitro during the susceptible period, a dose-dependent occurrence of embryonic bradycardia, arrhythmia and cardiac arrest has been noticed for almokalant and dofetilide (Spence et al 1994;Webster et al 1996) and L-691,121 (Ban et al 1994). The results in these in vivo and in vitro studies show a very good correlation between maternal concentrations, which were related with embryonic death, and concentrations that caused severe dysrhythmia.…”
Section: Discussionmentioning
confidence: 88%
“…In rat embryo, a susceptible period seems to exist between Days 9-14. Embryos cultured in vitro during this period show dose-dependent bradycardia, arrhythmia and cardiac arrest after exposure to almokalant, dofetilide and L-691,121 (Spence et al 1994;Webster et al 1996). Pharmacologically induced embryonic bradycardia and arrhythmia have been proposed to be the underlying mechanism for developmental toxicity observed after administration of these agents in vivo in rodents (Abrahamsson et al 1994;Webster et al 1996;Skö ld & Danielsson 2000).…”
The purpose of this study was to investigate the potential of sotalol to cause developmental toxicity in the pregnant rabbit. Sotalol is a b-adrenoceptor blocking drug which also has class III antiarrhythmic properties via Ikr channel blockade. Experiment 1: Nine pregnant New Zealand White rabbits were given doses of either 300, 225, or 150 mg/kg of sotalol during gestational days, called Days, 13-16 which resulted in total litter loss. Experiment 2: A single dose of sotalol, 100 or 150 mg/kg was administered during Days 8-17 to 15 rabbits. Dosing on Day 8, 9, or 10 resulted in a slightly higher incidence of embryonic death compared to historical controls. There was marked increased embryonic death of 55-90% (four does with total litter loss), decreased number of live foetuses per litter, and elevated mean foetal weight after dosing during Days 12-16. Experiment 3: 16 pregnant rabbits were administered single doses of sotalol of either 100, 85, 75, 60 or 50 mg/kg on Day 14. The main finding was increased embryonic death, which ranged from total litter loss to ∂30% at 50 mg/kg. At 50 mg/kg, the maternal C max , AUC 1-24 hr , and t 1/2 were approximately 45 mM, 340 mmol¿hr/l, and 6 hr, respectively. In conclusion, sotalol treatment resulted in embryonic death in the rabbit in early pregnancy in the same way as has been seen for other drugs with Ikr blocking properties (class III antiarrhythmics) in rodents. The observed developmental toxicity in the rabbit is most likely secondary to embryonic arrhythmia as has been shown in rodent studies. The results may indicate that Ikr blocking agents are developmental toxicants across species including man.
“…This idea has been supported by the observation of embryotoxic effects in pregnant rats, where application of IKr specific channel blocker, dofetilide, has been described to strongly impair the rhythm of embryonic hearts with lethal effects (Spence et al,1994;Webster et al, 1996). To explore the expression pattern of the IKr forming components KCNH2 (hERG) and KCNE2 (MiRP1), we analysed, by means of in situ hybridization, sagittal and transversal sections in late rat embryonic development.…”
Abbreviations: cNBD, cyclic nucleotide binding domain; cTnI, cardiac specific troponin I; dpc, dies post conceptionem; ERG, ether a go-go-related gene; hERG, human ERG; IKr, rapidly activating component of the delayed rectifier K + current; IKs, slowly
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.